LiveVox Announces Third Quarter 2022 Financial Results
LiveVox reported a 15.6% year-over-year increase in total revenue for Q3 2022, reaching $35.3 million. Contract revenue rose 21.4% to $28.0 million. Gross profit improved 31.3% to $22.4 million, with a gross margin of 63.4%, up from 55.8% in Q3 2021. The company reduced its net loss to $7.8 million, down from $11.3 million. Adjusted EBITDA loss was cut to $1.5 million from $6.3 million year-over-year. The outlook reflects careful consideration of growth strategies and market conditions.
- Total revenue increased 15.6% year-over-year to $35.3 million.
- Contract revenue grew 21.4% year-over-year, reaching $28.0 million.
- Gross profit rose 31.3% to $22.4 million.
- Gross margin improved to 63.4%, up from 55.8% in Q3 2021.
- Net loss decreased to $7.8 million compared to $11.3 million in Q3 2021.
- Adjusted EBITDA loss narrowed to $1.5 million from $6.3 million year-over-year.
- None.
Third quarter total revenue year-over-year growth of
Third quarter contract revenue year-over-year growth of
“We were encouraged by the early success of our pivot to a balanced growth strategy, especially beating the high end of our guidance for gross margin and Adjusted EBITDA,” said
Third Quarter 2022 Financial Highlights
-
Revenue: Total revenue was
for the third quarter of 2022, up$35.3 million 15.6% compared to for the third quarter of 2021.$30.5 million -
Contract Revenue: Contract revenue was
for the third quarter of 2022, up$28.0 million 21.4% compared to for the third quarter of 2021.$23.1 million -
Gross Profit and Gross Margin: Gross profit was
for the third quarter of 2022, up$22.4 million 31.3% compared to for the third quarter of 2021; Gross margin was$17.0 million 63.4% for the third quarter of 2022, compared to55.8% for the third quarter of 2021. -
Non-GAAP Gross Profit* and Non-GAAP Gross Margin*: Non-GAAP gross profit was
for the third quarter of 2022, up$23.4 million 28.9% compared to for the third quarter of 2021; Non-GAAP gross margin was$18.1 million 66.3% for the third quarter of 2022, compared to59.5% for the third quarter of 2021. -
Net loss: Net loss was
for the third quarter of 2022, compared to net loss of$7.8 million for the third quarter of 2021.$11.3 million -
Adjusted EBITDA*: Adjusted EBITDA loss was
for the third quarter of 2022, compared to Adjusted EBITDA loss of$1.5 million for the third quarter of 2021.$6.3 million
* Additional information regarding the non-GAAP financial measures discussed in this release, including an explanation of these measures and how each is calculated, is included below under the heading “Non-GAAP Financial Measures.” A reconciliation of GAAP to non-GAAP financial measures has also been provided in the financial tables included below.
Business Outlook
In determining the financial guidance to provide to investors, the Company considered its recent business trends and financial results, current growth plans, strategic initiatives, global economic outlook and the continued uncertainty of COVID-19 and its potential impact on the Company’s results.
-
Fourth Quarter of 2022 Guidance:
-
Total revenue is expected to be in the range of
to$33.7 million , representing growth of$35.2 million 6% to10% year-over-year. -
Contract revenue is expected to be in the range of
to$28.0 million , representing growth of$29.0 million 15% to19% year-over-year. -
Excess usage revenue is expected to be in the range of
to$5.7 million , representing decline of$6.2 million 24% to18% year-over-year. -
Adjusted EBITDA is expected to be in the range of
to$(1.6) million .$0.4 million
-
Total revenue is expected to be in the range of
-
Full Year 2022 Guidance:
-
Total revenue is expected to be in the range of
to$134.0 million , representing growth of$135.5 million 12% to14% year-over-year. -
Contract revenue is expected to be in the range of
to$108.0 million , representing growth of$109.0 million 19% to20% year-over-year. -
Excess usage revenue is expected to be in the range of
to$26.0 million , representing decline of$26.5 million 10% to8% year-over-year. -
Adjusted EBITDA loss is now expected to be in the range of
to$17.0 million .$15.0 million
-
Total revenue is expected to be in the range of
A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potential variability of, many of the future costs and expenses for which the Company adjusts, such as depreciation and amortization, long-term equity incentive bonus, stock-based compensation expense, interest income (expense), change in the fair value of warrant liability, other income (expense), provision for income taxes and severance costs, the effect of which may be significant.
Quarterly Conference Call
About
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, the quotations of management, statements relating to expected bookings, expected revenue and annual recurring revenue from contracts, growth expectations, and future financial results, including guidance for the 2022 fourth quarter and full fiscal year. These statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside LiveVox’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Any such forward-looking statements are made pursuant to the safe harbor provisions available under applicable securities laws and speak only as of the date of this presentation.
Important factors, among others, that may affect actual results or outcomes include risks or liabilities assumed as a result of our ability to meet financial and operating guidance, ability to achieve financial targets, and successfully manage capital expenditures; risks related to the high level of competition in the cloud contact center industry and the intense competition and competitive pressures from other companies in the industry in which the Company operates; risks related to the Company’s reliance on information systems and the ability to properly maintain the confidentiality and integrity of data; risks related to the occurrence of cyber incidents or a deficiency in cybersecurity protocols; risks related to the ability to obtain third-party software licenses for use in or with the Company’s products; general economic and business conditions, including but not limited to challenges associated with a tight labor market, inflationary pressures, volatility in foreign exchange rates, supply chain constraints, recessionary fears, and impacts from the invasion of
The information contained in this press release is summary information that is intended to be considered in the context of LiveVox’s
Consolidated Statements of Operations and Comprehensive Loss
|
|||||||||||||||
|
For the three months ended
|
|
For the nine months ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Revenue |
$ |
35,253 |
|
|
$ |
30,507 |
|
|
$ |
100,333 |
|
|
$ |
87,365 |
|
Cost of revenue |
|
12,893 |
|
|
|
13,479 |
|
|
|
39,073 |
|
|
|
46,274 |
|
Gross profit |
|
22,360 |
|
|
|
17,028 |
|
|
|
61,260 |
|
|
|
41,091 |
|
Operating expenses |
|
|
|
|
|
|
|
||||||||
Sales and marketing expense |
|
13,826 |
|
|
|
12,227 |
|
|
|
43,448 |
|
|
|
48,820 |
|
General and administrative expense |
|
7,188 |
|
|
|
7,642 |
|
|
|
22,202 |
|
|
|
37,159 |
|
Research and development expense |
|
7,553 |
|
|
|
8,130 |
|
|
|
24,210 |
|
|
|
44,479 |
|
Total operating expenses |
|
28,567 |
|
|
|
27,999 |
|
|
|
89,860 |
|
|
|
130,458 |
|
Loss from operations |
|
(6,207 |
) |
|
|
(10,971 |
) |
|
|
(28,600 |
) |
|
|
(89,367 |
) |
Interest expense, net |
|
896 |
|
|
|
1,033 |
|
|
|
2,390 |
|
|
|
2,918 |
|
Change in the fair value of warrant liability |
|
350 |
|
|
|
(300 |
) |
|
|
(134 |
) |
|
|
(675 |
) |
Other expense (income), net |
|
160 |
|
|
|
(460 |
) |
|
|
209 |
|
|
|
(435 |
) |
Total other expense, net |
|
1,406 |
|
|
|
273 |
|
|
|
2,465 |
|
|
|
1,808 |
|
Pre-tax loss |
|
(7,613 |
) |
|
|
(11,244 |
) |
|
|
(31,065 |
) |
|
|
(91,175 |
) |
Provision for income taxes |
|
159 |
|
|
|
100 |
|
|
|
474 |
|
|
|
187 |
|
Net loss |
$ |
(7,772 |
) |
|
$ |
(11,344 |
) |
|
$ |
(31,539 |
) |
|
$ |
(91,362 |
) |
Comprehensive loss |
|
|
|
|
|
|
|
||||||||
Net loss |
$ |
(7,772 |
) |
|
$ |
(11,344 |
) |
|
$ |
(31,539 |
) |
|
$ |
(91,362 |
) |
Other comprehensive loss, net of tax |
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment |
|
(159 |
) |
|
|
(41 |
) |
|
|
(361 |
) |
|
|
(27 |
) |
Net unrealized loss on marketable securities |
|
(316 |
) |
|
|
— |
|
|
|
(1,492 |
) |
|
|
— |
|
Total other comprehensive loss, net of tax |
|
(475 |
) |
|
|
(41 |
) |
|
|
(1,853 |
) |
|
|
(27 |
) |
Comprehensive loss |
$ |
(8,247 |
) |
|
$ |
(11,385 |
) |
|
$ |
(33,392 |
) |
|
$ |
(91,389 |
) |
Net loss per share |
|
|
|
|
|
|
|
||||||||
Net loss per share—basic and diluted |
$ |
(0.08 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.34 |
) |
|
$ |
(1.20 |
) |
Weighted average shares outstanding—basic and diluted |
|
92,351 |
|
|
|
91,444 |
|
|
|
91,800 |
|
|
|
76,122 |
|
Consolidated Balance Sheets
|
|||||||
|
As of |
||||||
|
|
|
|
||||
|
(Unaudited) |
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
22,594 |
|
|
$ |
47,217 |
|
Restricted cash, current |
|
100 |
|
|
|
100 |
|
Marketable securities, current |
|
47,540 |
|
|
|
7,226 |
|
Accounts receivable, net |
|
20,253 |
|
|
|
20,128 |
|
Deferred sales commissions, current |
|
3,079 |
|
|
|
2,691 |
|
Prepaid expenses and other current assets |
|
5,140 |
|
|
|
6,151 |
|
Total Current Assets |
|
98,706 |
|
|
|
83,513 |
|
Property and equipment, net |
|
2,923 |
|
|
|
3,010 |
|
|
|
47,481 |
|
|
|
47,481 |
|
Intangible assets, net |
|
17,518 |
|
|
|
20,195 |
|
Operating lease right-of-use assets |
|
5,420 |
|
|
|
5,483 |
|
Deposits and other |
|
427 |
|
|
|
664 |
|
Marketable securities, net of current |
|
— |
|
|
|
42,148 |
|
Deferred sales commissions, net of current |
|
7,388 |
|
|
|
6,747 |
|
Deferred tax asset, net |
|
131 |
|
|
|
— |
|
Total Assets |
$ |
179,994 |
|
|
$ |
209,241 |
|
|
|
|
|
||||
LIABILITIES & STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
4,123 |
|
|
$ |
6,490 |
|
Accrued expenses |
|
12,786 |
|
|
|
13,855 |
|
Deferred revenue, current |
|
1,249 |
|
|
|
1,307 |
|
Term loan, current |
|
841 |
|
|
|
561 |
|
Operating lease liabilities, current |
|
1,742 |
|
|
|
1,946 |
|
Finance lease liabilities, current |
|
18 |
|
|
|
26 |
|
Total current liabilities |
|
20,759 |
|
|
|
24,185 |
|
Long term liabilities: |
|
|
|
||||
Deferred revenue, net of current |
|
443 |
|
|
|
456 |
|
Term loan, net of current |
|
53,839 |
|
|
|
54,459 |
|
Operating lease liabilities, net of current |
|
4,043 |
|
|
|
4,046 |
|
Finance lease liabilities, net of current |
|
— |
|
|
|
11 |
|
Deferred tax liability, net |
|
— |
|
|
|
2 |
|
Warrant liability |
|
633 |
|
|
|
767 |
|
Other long-term liabilities |
|
338 |
|
|
|
337 |
|
Total liabilities |
|
80,055 |
|
|
|
84,263 |
|
|
|
|
|
||||
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Preferred stock, |
|
— |
|
|
|
— |
|
Common stock, |
|
9 |
|
|
|
9 |
|
Additional paid-in capital |
|
261,821 |
|
|
|
253,468 |
|
Accumulated other comprehensive loss |
|
(2,330 |
) |
|
|
(477 |
) |
Accumulated deficit |
|
(159,561 |
) |
|
|
(128,022 |
) |
Total stockholders’ equity |
|
99,939 |
|
|
|
124,978 |
|
Total liabilities & stockholders’ equity |
$ |
179,994 |
|
|
$ |
209,241 |
|
Consolidated Statements of Cash Flows
|
|||||||
|
For the nine months ended
|
||||||
|
|
2022 |
|
|
|
2021 |
|
Operating activities: |
|
|
|
||||
Net loss |
$ |
(31,539 |
) |
|
$ |
(91,362 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
873 |
|
|
|
1,475 |
|
Amortization of identified intangible assets |
|
2,677 |
|
|
|
3,358 |
|
Amortization of deferred loan origination costs |
|
81 |
|
|
|
102 |
|
Amortization of deferred sales commissions |
|
2,312 |
|
|
|
1,368 |
|
Non-cash lease expense |
|
1,369 |
|
|
|
1,207 |
|
Stock-based compensation expense |
|
8,878 |
|
|
|
1,458 |
|
Equity incentive bonus |
|
— |
|
|
|
32,863 |
|
Bad debt expense |
|
373 |
|
|
|
110 |
|
Loss on disposition of asset |
|
13 |
|
|
|
— |
|
Deferred income tax benefit |
|
(133 |
) |
|
|
(272 |
) |
Loss on sale of marketable securities |
|
42 |
|
|
|
— |
|
Amortization of premium paid on marketable securities |
|
346 |
|
|
|
— |
|
Change in the fair value of the warrant liability |
|
(134 |
) |
|
|
(675 |
) |
Offering cost associated with Warrants recorded as liabilities |
|
— |
|
|
|
41 |
|
Changes in assets and liabilities |
|
|
|
||||
Accounts receivable |
|
(498 |
) |
|
|
(2,648 |
) |
Other assets |
|
1,249 |
|
|
|
(2,514 |
) |
Deferred sales commissions |
|
(3,340 |
) |
|
|
(5,347 |
) |
Accounts payable |
|
(2,369 |
) |
|
|
1,725 |
|
Accrued expenses |
|
(1,945 |
) |
|
|
1,225 |
|
Deferred revenue |
|
(71 |
) |
|
|
(54 |
) |
Operating lease liabilities |
|
(1,467 |
) |
|
|
(1,202 |
) |
Other long-term liabilities |
|
— |
|
|
|
(2 |
) |
Net cash used in operating activities |
|
(23,283 |
) |
|
|
(59,144 |
) |
Investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(880 |
) |
|
|
(1,210 |
) |
Purchases of marketable securities |
|
(9,459 |
) |
|
|
— |
|
Proceeds from sale of marketable securities |
|
3,451 |
|
|
|
— |
|
Proceeds from maturities and principal paydowns of marketable securities |
|
5,961 |
|
|
|
— |
|
Proceeds from asset acquisition, net of cash paid |
|
— |
|
|
|
1,326 |
|
Net cash provided by (used in) investing activities |
|
(927 |
) |
|
|
116 |
|
Financing activities: |
|
|
|
||||
Proceeds from Merger and PIPE financing, net of cash paid |
|
— |
|
|
|
157,383 |
|
Repayments on loan payable |
|
(421 |
) |
|
|
(1,676 |
) |
Repayments of drawdown on line of credit |
|
— |
|
|
|
(4,672 |
) |
Debt issuance costs |
|
— |
|
|
|
(153 |
) |
Payments of contingent consideration liability |
|
— |
|
|
|
(5,969 |
) |
Repayments on finance lease obligations |
|
(19 |
) |
|
|
(331 |
) |
Payments of employees’ withholding taxes on net share settlement of share-based awards |
|
(513 |
) |
|
|
— |
|
Proceeds from the structured payable arrangement |
|
1,311 |
|
|
|
— |
|
Principal payments under the structured payable arrangement |
|
(435 |
) |
|
|
— |
|
Net cash provided by (used in) financing activities |
|
(77 |
) |
|
|
144,582 |
|
Effect of foreign currency translation |
|
(336 |
) |
|
|
(40 |
) |
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
(24,623 |
) |
|
|
85,514 |
|
Cash, cash equivalents, and restricted cash beginning of period |
|
47,317 |
|
|
|
19,566 |
|
Cash, cash equivalents, and restricted cash end of period |
$ |
22,694 |
|
|
$ |
105,080 |
|
|
For the nine months ended
|
||||
|
2022 |
|
2021 |
||
Supplemental disclosure of cash flow information: |
|
|
|
||
Interest paid |
$ |
2,619 |
|
$ |
2,828 |
Income taxes paid |
|
345 |
|
|
237 |
Supplemental schedule of noncash investing activities: |
|
|
|
||
Change in unrealized loss on marketable securities |
$ |
1,492 |
|
$ |
— |
Additional right-of-use assets |
|
1,261 |
|
|
3,246 |
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets (dollars in thousands):
|
As of |
||||
|
2022 |
|
2021 |
||
Cash and cash equivalents |
$ |
22,594 |
|
$ |
104,980 |
Restricted cash, current |
|
100 |
|
|
— |
Restricted cash, net of current |
|
— |
|
|
100 |
Total cash, cash equivalents and restricted cash |
$ |
22,694 |
|
$ |
105,080 |
Non-GAAP Financial Measures
Management uses non-GAAP financial measures to evaluate operating performance. We believe non-GAAP financial measures provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors.
There are material limitations associated with the use of non-GAAP financial measures since they exclude significant expenses and income that are required by GAAP to be recorded in our financial statements. The definitions of our non-GAAP measures may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may utilize metrics that are not similar to ours. We compensate for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.
Adjusted EBITDA
We monitor Adjusted EBITDA, a non-generally accepted accounting principle (“Non-GAAP”) financial measure, to analyze our financial results and believe that it is useful to investors, as a supplement to
Non-GAAP Gross Profit and Non-GAAP Gross Margin Percentage
Management uses Non-GAAP gross profit and Non-GAAP gross margin percentage to evaluate operating performance and to determine resource allocation among our various product offerings. We believe Non-GAAP gross profit and Non-GAAP gross margin percentage provide useful information to investors and others to understand and evaluate our operating results in the same manner as our management and board of directors and allows for better comparison of financial results among our competitors. Non-GAAP gross profit and Non-GAAP gross margin percentage may not be comparable to similarly titled measures of other companies because other companies may not calculate Non-GAAP gross profit and Non-GAAP gross margin percentage or similarly titled measures in the same manner as we do.
Please see tables below for a reconciliation of non-GAAP measures to the most directly comparable GAAP measures for the periods presented.
GAAP Net Loss to Adjusted EBITDA
|
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net loss |
$ |
(7,772 |
) |
|
$ |
(11,344 |
) |
|
$ |
(31,539 |
) |
|
$ |
(91,362 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
1,119 |
|
|
|
1,628 |
|
|
|
3,550 |
|
|
|
4,834 |
|
Long-term equity incentive bonus and stock-based compensation expenses |
|
2,976 |
|
|
|
2,069 |
|
|
|
8,878 |
|
|
|
72,035 |
|
Interest expense, net |
|
896 |
|
|
|
1,033 |
|
|
|
2,390 |
|
|
|
2,918 |
|
Change in the fair value of warrant liability |
|
350 |
|
|
|
(300 |
) |
|
|
(134 |
) |
|
|
(675 |
) |
Other expense (income), net |
|
160 |
|
|
|
(460 |
) |
|
|
209 |
|
|
|
(435 |
) |
Acquisition and financing related fees and expenses |
|
— |
|
|
|
480 |
|
|
|
10 |
|
|
|
1,521 |
|
Transaction-related costs |
|
98 |
|
|
|
531 |
|
|
|
281 |
|
|
|
1,834 |
|
|
|
— |
|
|
|
(11 |
) |
|
|
— |
|
|
|
135 |
|
Provision for income taxes |
|
159 |
|
|
|
100 |
|
|
|
474 |
|
|
|
187 |
|
Severance costs |
|
521 |
|
|
|
— |
|
|
|
521 |
|
|
|
— |
|
Adjusted EBITDA |
$ |
(1,493 |
) |
|
$ |
(6,274 |
) |
|
$ |
(15,360 |
) |
|
$ |
(9,008 |
) |
GAAP Gross Profit to Non-GAAP Gross Profit
|
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Gross profit |
$ |
22,360 |
|
|
$ |
17,028 |
|
|
$ |
61,260 |
|
|
$ |
41,091 |
|
Depreciation and amortization |
|
343 |
|
|
|
927 |
|
|
|
1,295 |
|
|
|
2,785 |
|
Long-term equity incentive bonus and stock-based compensation expenses |
|
284 |
|
|
|
190 |
|
|
|
999 |
|
|
|
9,877 |
|
Severance costs |
|
400 |
|
|
|
— |
|
|
|
400 |
|
|
|
— |
|
Non-GAAP gross profit |
$ |
23,387 |
|
|
$ |
18,145 |
|
|
$ |
63,954 |
|
|
$ |
53,753 |
|
|
|
|
|
|
|
|
|
||||||||
Gross margin % |
|
63.4 |
% |
|
|
55.8 |
% |
|
|
61.1 |
% |
|
|
47.0 |
% |
Non-GAAP gross margin % |
|
66.3 |
% |
|
|
59.5 |
% |
|
|
63.7 |
% |
|
|
61.5 |
% |
The following table presents the stock-based compensation expenses included in Company’s results of operations for the three and nine months ended
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Cost of revenue |
$ |
284 |
|
$ |
154 |
|
$ |
999 |
|
$ |
182 |
Sales and marketing expense |
|
706 |
|
|
255 |
|
|
2,184 |
|
|
312 |
General and administrative expense |
|
1,055 |
|
|
354 |
|
|
2,655 |
|
|
490 |
Research and development expense |
|
931 |
|
|
417 |
|
|
3,040 |
|
|
474 |
Total stock-based compensation |
$ |
2,976 |
|
$ |
1,180 |
|
$ |
8,878 |
|
$ |
1,458 |
The following table presents the long-term equity incentive bonus included in Company’s results of operations for the three and nine months ended
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Cost of revenue |
$ |
— |
|
$ |
36 |
|
$ |
— |
|
$ |
9,695 |
Sales and marketing expense |
|
— |
|
|
313 |
|
|
— |
|
|
18,401 |
General and administrative expense |
|
— |
|
|
194 |
|
|
— |
|
|
18,595 |
Research and development expense |
|
— |
|
|
346 |
|
|
— |
|
|
23,886 |
Total long-term equity incentive bonus |
$ |
— |
|
$ |
889 |
|
$ |
— |
|
$ |
70,577 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108006134/en/
Investor Contacts:
awaadt@livevox.com
livevoxIR@icrinc.com
Press contacts:
nbandy@livevox.com
livevoxPR@icrinc.com
Source:
FAQ
What was LiveVox's total revenue for Q3 2022?
How much did LiveVox's contract revenue grow in Q3 2022?
What is LiveVox's gross margin for Q3 2022?
What was the net loss reported by LiveVox in Q3 2022?